Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus

Cancer Genetics and Cytogenetics

Volumn 127, Issue 1, 2001, Pages 7-15

  Kiyozuka, Yasuhiko ^a   Nakagawa, Hiroyuki ^a   Uemura, Yoshiko ^a   Senzaki, Hideto ^a   Yamamoto, Akitsugu ^a   Noguchi, Taketoshi ^b   Mizuta, Hirohisa ^b   Nakanishi, Kohji ^b   Nakano, Shiro ^b   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Saiseikai Nara Hospital 643 Hachijocho   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HYALURONIC ACID; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

AGED; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL LINE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; PRIORITY JOURNAL; UTERUS CANCER;

AGED; ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS, HORMONAL; CELL DIVISION; CELL NUCLEUS; CYTOPLASM; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; HYALURONIC ACID; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

MUS MUSCULUS;

EID: 0035335505     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00413-1     Document Type: Article

References (56)

1. Malignant fibrous histiocytoma. An analysis of 200 cases
2. Malignant giant cell tumor of the uterus
3. Primary malignant fibrous histiocytoma of the endometrium
4. Primary malignant fibrous histiocytoma of the uterus-ultrastructural and immunocytochemical studies of two cases
5. Malignant fibrous histiocytoma of the uterus
6. Primary malignant fibrous histiocytoma of the uterine body
7. Cytological patterns of primary malignant fibrous histiocytoma
8. Malignant fibrous histiocytoma of the uterus. Some immunohistochemical and ultrastructural observations
9. Malignant fibrous histiocytoma of the uterus; report of a case
10. Mxoid malignant fibrous histiocytoma versus myxoid liposarcoma. A comparative ultrastructural study
11. Cultural characteristics of malignant histiocytomas and fibrous xanthomas
12. Immunohistochemistry of markers of histiomonocytic cells in malignant fibrous histiocytomas; a monoclonal antibody study
13. Malignant fibrous histiocytoma; an ultrastructural study of eleven cases
14. Chemically induced transplantable malignant fibrous histiocytoma of the rat; Analyses with immunohistochemistry, immunoelectron microscopy, and 3H-thymidine autoradiography
15. A study of analyze the origin of tumor cells in malignant fibrous histiocytomas; a multiparametric characterization
16. An immunohistochemical study of differentiation in malignant fibrous histiocytoma
17. Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin; immunohistochemical studies with monoclonal anti-MFH antibodies
18. Soft tissue sarcoma with additional anaplastic components; a clinicopathologic and immunohistochemical study of 27 cases
19. Malignant fibrous histiocytoma; A tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines
20. Two cell lines with epithelial cell-like characteristics established from malignant fibrous histiocytomas
21. Biological behavior of cloned cells of human malignant fibrous histiocytoma in vivo and in vitro
22. Origin and relationship between different cell types in MFH
23. Production of monocyte chemoattractant protein-1 by malignant fibrous histiocytoma; relation to the origin of histiocyte-like cells
24. A case of malignant fibrous histiocytoma; the use of tissue culture for identification of the histiocytic nature of the tumor cells
25. Characterization of a human myxoid malignant fibrous histiocytoma cell line, OH931
26. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen
27. Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity
28. Estrogen receptor variants in normal human mammary tissue
29. Use of reverse transcription-polymerase chain reaction methodology to detect estrogen-regulated gene expression in small breast cancer specimens
30. Expression of estrogen receptor β messenger RNA variant in breast cancer
31. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines
32. Retinoic acids increase 17 beta-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoylphorbol-13-acetate, and cyclic adenosine 3′,5′-monophosphate only in JEG-3 cells
33. Optimal prefixation of cells to demonstrate apoptosis by the TUNEL method
34. Glioma invasion in vitro is mediated by CD44-hyaluronan interactions
35. In vitro invasiveness of human epithelioid-sarcoma cell lines; association with cell motility and inverse correlation with the expression of tissue inhibitor of metalloproteinases
36. Expression of E-cadherin in bone and soft tissue sarcomas; a possible role in epithelial differentiation
37. Angiogenesis; Models and modulators
38. Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma
39. Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy
40. Predominant p53 G→A transition mutation and enhanced cell proliferation in uterine sarcomas of CBA mice treated with 1,2-dimethylhydrazine
41. Estrogen and progesterone receptors in uterine sarcomas
42. Changes in expression of estrogen receptors α and β in relation to progesterone receptor and pS2 status in normal and malignant endometrium
43. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
44. Oestrogen receptor (ER)-α and ER-β isoforms in normal and endometrial and endometriosis-derived stromal cells
45. Estrogen receptor alpha (ER-α) and beta (ER-β) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines; down-regulation of ER-β in neoplastic tissues
46. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro
47. Female sex hormone stimulates cultured human keratinocytes proliferation and its RNA- and protein-synthetic activities
48. Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells
49. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7
50. Cloning of the human oestrogen receptor cDNA
51. Chemotherapy for advanced or recurrent gynecologic cancer
52. Mechanisms of action of progestational agents
53. Antiestrogen treatment of cancer; an overview
54. Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer
55. R-6